You are here: All Products  > CANbridge Completes Biomarker Study of Cancer Drug; Gains Taiwan Rights

CANbridge Completes Biomarker Study of Cancer Drug; Gains Taiwan Rights

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products